Full Committee Hearing

Origins of COVID-19: An Examination of Available Evidence

Date: June 18, 2024
Time: 10:00am
Location: Senate Dirksen Building, SD-342

Member Statements

Chairman

Gary Peters

(D -
 MI)

Witnesses

Panel I

GREGORY D. KOBLENTZ, PH.D.

Associate Professor and Director, Biodefense Graduate Program
George Mason University

Panel I

ROBERT F. GARRY, PH.D.

Professor and Associate Dean School of Medicine
Tulane University

Panel I

STEVEN C. QUAY, M.D., PH.D.

Chief Executive Officer Atossa Therapeutics, Inc. and Former Faculty
Stanford University School of Medicine

Panel I

RICHARD H. EBRIGHT, PH.D.

Board of Governors Professor of Chemistry and Chemical Biology and Laboratory Director, Waksman Institute of Microbiology
Rutgers University